Table 3.
TNFα | Positive + high positive (n = 10) | Low positive (n = 9) | P-value |
---|---|---|---|
Gender | |||
Male | 5 (50%) | 5 (55.5%) | 1 |
Female | 5 (50%) | 4 (44.4%) | |
Liver CMV PCR positive | 9 (90%) | 7 (77.7%) | 0.582 |
Blood CMV PCR positive | 9 (90%) | 8 (88.8%) | 1 |
CMV IgM positive | 4 (40%) | 2 (22.2%) | 0.628 |
CMV IgG positive | 6(60%) | 7 (77.7%) | 0.628 |
Diagnosis | |||
Biliary atresia | 6 (60%) | 2 (22.2%) | 0.1698 |
Neonatal hepatitis | 4 (40%) | 7 (77.7%) | |
Outcome | |||
Recovered | 5 (50%) | 4 (44.4) | 0.8363 |
Chronic liver disease | 2 (20%) | 1 (11.1%) | |
On follow-up | 1 (10%) | 1 (11.1%) | |
Lost to follow-up | 2 (20%) | 3 (33.3%) |
CMV – cytomegalovirus, IgG – immunoglobulin G, IgM – immunoglobulin M